Sartorius

Sartorius Short-term Debt

The Short-Term Debt of Sartorius (SRT.DE) as of Nov 11, 2026 is 926.40 M EUR. In the previous year, Short-Term Debt was 393.10 M EUR — a change of 135.67% (higher).

Short-term Debt

926.40 MEUR

YoY

135.67%

Last updated:

Short-Term Debt of Sartorius is 2025 926.40 M EUR. Short-Term Debt of Sartorius was 2024 393.10 M EUR. It decreases by 135.67% higher compared to the previous year.

The Sartorius Short-term Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Short-term Debt
Date
Short-term Debt
Jan 1, 2018
109.98 M EUR
Jan 1, 2019
187.62 M EUR
Jan 1, 2020
195.48 M EUR
Jan 1, 2021
337.40 M EUR
Jan 1, 2022
555.00 M EUR
Jan 1, 2023
288.00 M EUR
Jan 1, 2024
393.10 M EUR
Jan 1, 2025
926.40 M EUR
The Sartorius Short-term Debt history
YEARShort-term DebtYoY
926.40 MEUR+135.67%
393.10 MEUR+36.49%
288.00 MEUR-48.11%
555.00 MEUR+64.49%
337.40 MEUR+72.60%
195.48 MEUR+4.19%
187.62 MEUR+70.60%
109.98 MEUR+62.76%
67.57 MEUR-29.60%
95.99 MEUR+212.21%
30.74 MEUR+129.26%
13.41 MEUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sartorius Stock analysis

What does Sartorius do? Sartorius AG is a globally operating company specializing in the development and manufacturing of laboratory equipment and process technologies. It was founded in 1870 by industrialist and entrepreneur Florenz Sartorius in Göttingen, Germany. The company initially focused on the sale of scales, weights, and measuring instruments but has since expanded and diversified its product line. Today, Sartorius AG is a world leader in the bioprocessing and laboratory equipment sectors and is known for its innovative products and procedures. The company's business model revolves around the development of high-tech products for applications in biotechnology, pharmaceuticals, and the food industry. It operates in two main business segments: Bioprocess Solutions and Lab Products & Services. The Bioprocess Solutions segment provides solutions and services for biopharmaceutical production, including filtration, fermentation, fluid management, and cell cultures. The products in this segment are typically disposable consumables used in the production of biopharmaceutical agents. The Lab Products & Services segment offers a wide range of laboratory equipment, from scales and microbiology equipment to ultrafiltration devices. These instruments are used by researchers and scientists in academic, industrial, and pharmaceutical laboratories worldwide. Furthermore, an important part of Sartorius' portfolio includes bioreactors and fermenters. These specialized devices are used for cultivating cells and microorganisms and are particularly important in biotechnology and vaccine production. Sartorius has established itself as a leader in this field through its innovative and high-performance products. In addition to the pharmaceutical, biotechnology, and laboratory sectors, Sartorius is also active in environmental technology. The company provides products and services for water analysis and purification, which are in demand in industries such as pharmaceuticals, food production, and environmental analysis due to their precise and reliable results. Sartorius demonstrates its innovation through the use of technologies such as machine learning and artificial intelligence. For example, the company offers the "Ambr" solution for fast and reliable modeling of production scenarios for biopharmaceutical agents. Machine learning techniques are employed to generate more data and make better decisions. Overall, Sartorius AG is a global company with a wide range of products and services for the biotechnology, pharmaceutical, chemical, and food industries. The company's innovation is evident in its continuous advancement of procedures, technologies, and products. With a strong market position and clear strategic direction, Sartorius will continue to be an important player in the industry and support the work of researchers and scientists worldwide with its high-performance products. Sartorius is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sartorius stock

Short-Term Debt of Sartorius is 926.40 M EUR in 2025.

Short-Term Debt of Sartorius changed from 393.10 M EUR to 926.40 M EUR, representing a 135.67% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Short-Term Debt Sartorius since 2006 – with annual values, charts, and detailed analysis.

Short-term debt represents borrowings due within one year. High short-term debt relative to cash can signal liquidity risk.

Short-Term Debt's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Short-Term Debt's Sartorius historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Sartorius

All Key Metrics — Sartorius